Skip to main content

Table 2 Comorbidity in the investigated patient groups

From: No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea

Disease

Number of patients with a given disease

 

OSAS n = 27

CPAP-OSAS n = 22

Controls n = 11

Arterial hypertension

16

16

4

Ischemic heart disease

7

7

2

Diabetes

2

4

0

Gout

0

4

0

  1. OSAS – patients with untreated OSAS; CPAP-OSAS – patients with OSAS treated successfully after a first attempt with CPAP, controls – subjects without OSAS.
Back to article page

Journal of Negative Results in BioMedicine

ISSN: 1477-5751

Contact us